Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • Resources
  • Blog

Revvityブログ

発見から治療までのイノベーションを促進

Latest

Optimizing functional genomics research tools by aligning their design with the ongoing evolution of the genome.

Functional Genomic Screening October 30, 2025 - 3 min read
Read
NGS

PIWI-interacting RNAs, a unique class of small RNAs.

August 29, 2025 - 4 min read
Read
NGS

Introducing GlycoRNAs, a new frontier in small RNA biology.

August 29, 2025 - 5 min read
Read
NGS

Improving Read 2 quality on Illumina NovaSeq X/X Plus PCR-free runs.

August 28, 2025 - 3 min read
Read
NGS

Discordant mapping of R1 and R2 in WGS studies: understanding Illumina paired-end sequencing.

August 28, 2025 - 3 min read
Read
NGS

Assessing error suppression strategies: a technical review of simplex and duplex UMIs.

August 26, 2025 - 4 min read
Read
Reproductive Health

Closing the gap: how Revvity and Women’s Health Hub Finland are advancing women’s healthcare.

August 25, 2025 - 3 min read
Read
NGS

Precision profiling of extracellular vesicle small RNAs.

August 25, 2025 - 2 min read
Read
NGS

Poly(A) selection vs rRNA depletion: guide for picking the right upstream method.

August 25, 2025 - 3 min read
Read
Reproductive Health

Building tomorrow - the professional journey of an SMA scientist.

August 25, 2025 - 2 min read
Read
Neurodegeneration

Validating brain-penetrating nanobodies with HTRF GPCR second messenger and receptor binding assays.

August 20, 2025 - 5 min read
Read
Pagination
  • First page « 最初
  • Previous page Previous
  • ページ 1
  • ページ 2
  • Current page 3
  • ページ 4
  • ページ 5
  • ページ 6
  • ページ 7
  • ページ 8
  • ページ 9
  • …
  • Next page Next
  • Last page 最後 »
line

ご質問がございましたら、
お気軽にお問い合わせください。

お問合せ
Revvity Logo

©2025 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.